Chronological Milestones in American Meat and Poultry Inspection

Historical Review

Austin J In Vitro Fertili. 2014;1(1): 5.

Chronological Milestones in American Meat and Poultry Inspection

Herbert W Ockerman* and Lopa Basu

The Ohio University (OSU), USA

*Corresponding author: Herbert W Ockerman, The Ohio University (OSU), USA

Received: September 11, 2014; Accepted: October 24, 2014; Published: October 30, 2014

Introduction

Herbert W Ockerman has been connected to the food industry since the 6th grade (WW2). He was working in the local supermarket when the butcher was drafted; so at this age he became the butcher. Also, on the farm, he participated in harvesting animals and curing meat tissue. When OSU cooperated with the USDA, he taught biochemistry of muscle tissue and statistics to approximately 2,000 lay and veterinary inspectors. He has also been involved in meat research and teaching for 52 years at OSU. Consequently, he has seen most of these meat and poultry inspections developed and being implemented.

History of Meat and Poultry Inspection

References

  1. Songer JG. Clostridial enteric diseases of domestic animals. Clin Microbiol Rev. 1996; 9: 216-234.
  2. Keel MK, Songer JG. The comparative pathology of Clostridium difficile-associated disease. Vet Pathol. 2006; 43: 225-240.
  3. Båverud V. Clostridium difficile diarrhea: infection control in horses. Vet Clin North Am Equine Pract. 2004; 20: 615-630.
  4. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009; 7: 526-536.
  5. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med. 1998; 49: 375-390.
  6. Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med. 2002; 162: 2177-2184.
  7. Diab SS, Rodriguez-Bertos A, Uzal FA. Pathology and diagnostic criteria of Clostridium difficile enteric infection in horses. Vet Pathol. 2013; 50: 1028-1036.
  8. Ruby R, Magdesian KG, Kass PH. Comparison of clinical, microbiologic, and clinicopathologic findings in horses positive and negative for Clostridium difficile infection. J Am Vet Med Assoc. 2009; 234: 777-784.
  9. Diab SS, Songer G, Uzal FA. Clostridium difficile infection in horses: a review. Vet Microbiol. 2013; 167: 42-49.
  10. Ehrich M, Perry BD, Troutt HF, Dellers RW, Magnusson RA. Acute diarrhea in horses of the Potomac River area: examination for clostridial toxins. J Am Vet Med Assoc. 1984; 185: 433-435.
  11. Donaldson MT, Palmer JE. Prevalence of Clostridium perfringens enterotoxin and Clostridium difficile toxin A in feces of horses with diarrhea and colic. J Am Vet Med Assoc. 1999; 215: 358-361.
  12. Weese JS, Staempfli HR, Prescott JF. A prospective study of the roles of clostridium difficile and enterotoxigenic Clostridium perfringens in equine diarrhoea. Equine vet J. 2001; 33: 403-409.
  13. Madewell BR, Tang YJ, Jang S, Madigan JE, Hirsh DC, Gumerlock PH, et al. Apparent outbreaks of Clostridium difficile-associated diarrhea in horses in a veterinary medical teaching hospital. J Vet Diagn Invest. 1995; 7: 343-346.
  14. Larsen J. Acute colitis in adult horses. A review with emphasis on aetiology and pathogenesis. Vet Q. 1997; 19: 72-80.
  15. Baverud V, Franklin A, Gunnarsson A, Gustafsson A, Hellander-Edman A. Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia. Equine Vet J. 1998; 30: 482-488.
  16. Båverud V, Gustafsson A, Franklin A, Aspán A, Gunnarsson A. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet J. 2003; 35: 465-471.
  17. Medina-Torres CE, Weese JS, Staempfli HR. Prevalence of Clostridium difficile in horses. Vet Microbiol. 2011; 152: 212-215.
  18. Ossiprandi MC, Buttrini M, Bottarelli E, Zerbini L. Preliminary molecular analysis of Clostridium difficile isolates from healthy horses in northern Italy. Comp Immunol Microbiol Infect Dis. 2010; 33: e25-29.
  19. Britton RA, Young VB. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 2012; 20: 313-319.
  20. Britton RA, Young VB. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology. 2014; 146: 1547-1553.
  21. Janoir C, Pechine S, Grosdidier C, Collignon A. Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins. J Bacteriol. 2007; 189: 7174-7180.
  22. Calabi E, Ward S, Wren B, Paxton T, Panico M, Morris H, et al. Molecular characterization of the surface layer proteins from Clostridium difficile. Mol Microbiol. 2001; 40: 1187-1199.
  23. Waligora AJ, Hennequin C, Mullany P, Bourlioux P, Collignon A, Karjalainen T. Characterization of a cell surface protein of Clostridium difficile with adhesive properties. Infect Immun. 2001; 69: 2144-2153.
  24. Hennequin C, Porcheray F, Waligora-Dupriet A, Collignon A, Barc M, Bourlioux P, et al. GroEL (Hsp60) of Clostridium difficile is involved in cell adherence. Microbiology. 2001; 147: 87-96.
  25. Tasteyre A, Barc MC, Collignon A, Boureau H, Karjalainen T. Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect Immun. 2001; 69: 7937-7940.
  26. Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, Viswanathan VK. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes. 2012; 3: 121-134.
  27. Péchiné S, Hennequin C, Boursier C, Hoys S, Collignon A. Immunization using GroEL decreases Clostridium difficile intestinal colonization. PLoS One. 2013; 8: e81112.
  28. Elliott B, Chang BJ, Golledge CL, Riley TV. Clostridium difficile-associated diarrhoea. Intern Med J. 2007; 37: 561-568.
  29. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med. 1994; 330: 257-262.
  30. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005; 18: 247-263.
  31. Rineh A, Kelso MJ, Vatansever F, Tegos GP, Hamblin MR. Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther. 2014; 12: 131-150.
  32. Tonna I, Welsby PD. Pathogenesis and treatment of Clostridium difficile infection. Postgrad Med J. 2005; 81: 367-369.
  33. Jank T, Aktories K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 2008; 16: 222-229.
  34. Pruitt RN, Lacy DB. Toward a structural understanding of Clostridium difficile toxins A and B. Front Cell Infect Microbiol. 2012; 2: 28.
  35. Carter GP, Lyras D, Allen DL, Mackin KE, Howarth PM, O'Connor JR, et al. Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol. 2007; 189: 7290-7301.
  36. Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis. 2007; 45: 222-227.
  37. Stare BG, Delmée M, Rupnik M. Variant forms of the binary toxin CDT locus and tcdC gene in Clostridium difficile strains. J Med Microbiol. 2007; 56: 329-335.
  38. Carroll KC, Bartlett JG. Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu Rev Microbiol. 2011; 65: 501-521.
  39. Bacci S, Mølbak K, Kjeldsen MK, Olsen KE. Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis. 2011; 17: 976-982.
  40. Davies AH, Roberts AK, Shone CC, Acharya KR. Super toxins from a super bug: structure and function of Clostridium difficile toxins. Biochem J. 2011; 436: 517-526.
  41. Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR. Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun. 1997; 65: 1402-1407.
  42. Schwan C, Stecher B, Tzivelekidis T, van Ham M, Rohde M, Hardt WD, et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 2009; 5: e1000626.
  43. Worsley MA. Infection control and prevention of Clostridium difficile infection. J Antimicrob Chemother. 1998; 41 Suppl C: 59-66.
  44. Chapman AM. Acute diarrhea in hospitalized horses. Vet Clin North Am Equine Pract. 2009; 25: 363-380.
  45. Uzal FA, Diab SS, Blanchard P, Moore J, Anthenill L, Shahriar F, et al. Clostridium perfringens type C and Clostridium difficile co-infection in foals. Vet Microbiol. 2012; 156: 395-402.
  46. Songer JG, Trinh HT, Dial SM, Brazier JS, Glock RD. Equine colitis X associated with infection by Clostridium difficile NAP1/027. J Vet Diagn Invest. 2009; 21: 377-380.
  47. Thean S, Elliott B, Riley TV. Clostridium difficile in horses in Australia--a preliminary study. J Med Microbiol. 2011; 60: 1188-1192.
  48. Frederick J, Giguere S, Sanchez LC. Infectious agents detected in the feces of diarrheic foals: a retrospective study of 233 cases (2003-2008). J Vet Intern Med. 2009; 23: 1254-1260.
  49. Weese JS, Toxopeus L, Arroyo L. Clostridium difficile associated diarrhoea in horses within the community: predictors, clinical presentation and outcome. Equine veterinary journal. 2006; 38: 185-188.
  50. Pothoulakis C, Castagliuolo I, Kelly CP, Lamont JT. Clostridium difficile-associated diarrhea and colitis: pathogenesis and therapy. Int J Antimicrob Agents. 1993; 3: 17-32.
  51. Jones RL, Adney WS, Alexander AF, Shideler RK, Traub-Dargatz JL. Hemorrhagic necrotizing enterocolitis associated with Clostridium difficile infection in four foals. J Am Vet Med Assoc. 1988; 193: 76-79.
  52. Magdesian KG, Hirsh DC, Jang SS, Hansen LM, Madigan JE. Characterization of Clostridium difficile isolates from foals with diarrhea: 28 cases (1993-1997). J Am Vet Med Assoc. 2002; 220: 67-73.
  53. Brewer BD, Koterba AM. Development of a scoring system for the early diagnosis of equine neonatal sepsis. Equine Vet J. 1988; 20: 18-22.
  54. Magdesian KG. Neonatal foal diarrhea. Vet Clin North Am Equine Pract. 2005; 21: 295-312, vi.
  55. Goldenberg SD, Cliff PR, French GL. Laboratory diagnosis of Clostridium difficile infection. Journal of clinical microbiology. 2010; 48: 3048-3049.
  56. Le Guern R, Wallet F. [Laboratory diagnosis of Clostridium difficile infection]. Ann Biol Clin (Paris). 2013; 71: 395-400.
  57. Kuhl SJ, Tang YJ, Navarro L, Gumerlock PH, Silva J, Jr. Diagnosis and monitoring of Clostridium difficile infections with the polymerase chain reaction. Clin Infect Dis. 1993; 16: S234-238.
  58. Tang YJ, Gumerlock PH, Weiss JB, Silva J Jr. Specific detection of Clostridium difficile toxin A gene sequences in clinical isolates. Mol Cell Probes. 1994; 8: 463-467.
  59. Sloan LM, Duresko BJ, Gustafson DR, Rosenblatt JE. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol. 2008; 46: 1996-2001.
  60. Alcala L, Sanchez-Cambronero L, Catalan MP, Sanchez-Somolinos M, Pelaez MT, Marin M, et al. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J Clin Microbiol. 2008; 46: 3833-3835.
  61. Medina-Torres CE, Weese JS, Staempfli HR. Validation of a commercial enzyme immunoassay for detection of Clostridium difficile toxins in feces of horses with acute diarrhea. J Vet Intern Med. 2010; 24: 628-632.
  62. Jones PA, Bain FT, Byars TD, David JB, Boston RC. Effect of hydroxyethyl starch infusion on colloid oncotic pressure in hypoproteinemic horses. J Am Vet Med Assoc. 2001; 218: 1130-1135.
  63. Blikslager AT. Treatment of gastrointestinal ischemic injury. Vet Clin North Am Equine Pract. 2003; 19: 715-727.
  64. Powell DG. Equine infectious respiratory disease. Vet Rec. 1975; 96: 30-34.
  65. Weese JS, Cote NM, deGannes RV. Evaluation of in vitro properties of di-tri-octahedral smectite on clostridial toxins and growth. Equine Vet J. 2003; 35: 638-641.
  66. Desrochers AM, Dolente BA, Roy MF, Boston R, Carlisle S. Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis. J Am Vet Med Assoc. 2005; 227: 954-959.
  67. Castagliuolo I, Riegler MF, Valenick L, LaMont JT, Pothoulakis C. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun. 1999; 67: 302-307.
  68. Boosman R, Németh F. [Pathogenesis and drug therapy of acute laminitis in horses: a literature review]. Tijdschr Diergeneeskd. 1988; 113: 1237-1246.
  69. Wylie CE, Collins SN, Verheyen KL, Newton JR. Risk factors for equine laminitis: a case-control study conducted in veterinary-registered horses and ponies in Great Britain between 2009 and 2011. Vet J. 2013; 198: 57-69.
  70. Slater MR, Hood DM, Carter GK. Descriptive epidemiological study of equine laminitis. Equine Vet J. 1995; 27: 364-367.
  71. Hacek DM, Ogle AM, Fisher A, Robicsek A, Peterson LR. Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile. Am J Infect Control. 2010; 38: 350-353.
  72. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108: 478-498.

Download PDF

Citation: Zhang K, Martinod S and Sun X. Clostridium Difficile Infection in Horses. Austin J Vet Sci & Anim Husb. 2014;1(1): 5. ISSN:2472-3371

Home
Journal Scope
Online First
Current Issue
Editorial Board
Instruction for Authors
Submit Your Article
Contact Us